Organogenesis Holdings Inc (ORGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -6,668 | -28,235 | -18,843 | 861 | -6,812 |
| Depreciation Amortization | 19,925 | 12,938 | 6,283 | 25,374 | 18,954 |
| Income taxes - deferred | -6,129 | -2,292 | -1,266 | -10,719 | -7,887 |
| Accounts receivable | -64,325 | -13,637 | 5,668 | -31,800 | -22,996 |
| Accounts payable and accrued liabilities | 643 | 1,637 | -2,496 | -2,372 | -6,022 |
| Other Working Capital | -88,713 | -58,833 | -20,713 | -48,889 | -42,110 |
| Other Operating Activity | 95,538 | 35,614 | 11,432 | 81,753 | 70,144 |
| Operating Cash Flow | $-49,729 | $-52,808 | $-19,935 | $14,208 | $3,271 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -9,499 | -7,264 | -3,626 | -10,032 | -6,671 |
| Investing Cash Flow | $-9,499 | $-7,264 | $-3,626 | $-10,032 | $-6,671 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -869 | -573 | -285 | -67,644 | -5,023 |
| Common Stock Issued | 155 | 25 | 25 | 1,247 | 184 |
| Common Stock Repurchased | N/A | N/A | N/A | -25,479 | N/A |
| Other Financing Activity | -11,837 | -1,796 | -1,796 | 119,513 | -1,173 |
| Financing Cash Flow | $-12,551 | $-2,344 | $-2,056 | $27,637 | $-6,012 |
| Beginning Cash Position | 136,151 | 136,151 | 136,151 | 104,338 | 104,338 |
| End Cash Position | 64,372 | 73,735 | 110,534 | 136,151 | 94,926 |
| Net Cash Flow | $-71,779 | $-62,416 | $-25,617 | $31,813 | $-9,412 |
| Free Cash Flow | |||||
| Operating Cash Flow | -49,729 | -52,808 | -19,935 | 14,208 | 3,271 |
| Capital Expenditure | -9,499 | -7,264 | -3,626 | -10,032 | -6,671 |
| Free Cash Flow | -59,228 | -60,072 | -23,561 | 4,176 | -3,400 |